The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
This brief summarizes key findings and themes from the COVID-19 Vaccine Monitor project that is tracking the dynamic nature of the U.S. public’s attitudes and experiences with COVID-19 vaccination, and is based on more than 11,000 interviews conducted since December 2020.
This report provides an analysis of donor government funding to address the HIV response in low- and middle-income countries in 2020, the latest year available, as well as trends over time. It includes both bilateral funding from donors and their multilateral contributions to the Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund), UNITAID, and Joint United Nations Programme on HIV/AIDS (UNAIDS).
Before the FDA expanded the Pfizer-BioNTech COVID-19 vaccine emergency use authorization for 12 to 15 year olds this week, the latest KFF COVID-19 Vaccine Monitor reported that 30 percent of parents of children ages 12 to 15 said they would get their child vaccinated right away.
This brief describes nonelderly adults with opioid use disorder, including their demographic characteristics and insurance status, and compares utilization of treatment services among those with Medicaid to those with other types of coverage. It also describes Medicaid financing for opioid treatment and the ways in which Medicaid promotes access to treatment for enrollees with OUD.
This issue brief provides an overview of the Medicare Part D prescription drug benefit market for 2022, with a primary focus on stand-alone drug plans. It includes national and state-level data on plan availability, premiums, benefit design, cost sharing, information about premium-free plans for low-income beneficiaries, and information about the national Part D drug plans available in 2022.
This post examines characteristics of adolescents ages 12 to 15 across in the United States to inform COVID-19 vaccination efforts once they become eligible to receive a vaccine.
The latest KFF COVID-19 Vaccine Monitor finds that those hardest hit by the mental health impacts of the coronavirus pandemic have been younger people and women, including mothers. This analysis of polling data explores who has been hardest hit by mental health impacts of the COVID-19 pandemic, how experience with COVID-19 related death and worry about getting sick impact mental health. It also explores problems with access to mental health care and treatment during the…
More than half (54%) of rural adults say they have already gotten at least one dose of a COVID-19 vaccine or will do so as soon as possible, as rural residents report less issues with both supply and access than those living in urban and suburban areas, according to a new KFF COVID-19 Vaccine Monitor report focused on rural America. A somewhat larger share of rural residents (39%) than those living in urban (31%) or suburban…
More than half of those who received their first dose of a COVID-19 vaccine through a community health center were people of color, suggesting that health centers appear to be doing a better job of reaching people of color than are overall vaccination efforts, finds a new KFF analysis. People of color accounted for 54 percent of people who got their first dose of the vaccine through a health center, the analysis finds, including 26 percent…
This post explains the new Medicaid Postpartum Expansion option included in The American Rescue Plan Act and raises some questions that policymakers are likely to grapple with as the implementation unfolds.
© 2026 KFF
